Cirrhosis Registry of Hospitalized Patients
Launched by F.D. ROOSEVELT TEACHING HOSPITAL WITH POLICLINIC BANSKA BYSTRICA · Feb 21, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Cirrhosis Registry of Hospitalized Patients is a study aimed at understanding the experiences and health of adults who are admitted to the hospital due to liver cirrhosis. Cirrhosis is a serious condition where the liver becomes damaged and cannot function properly. This trial is important because it will collect information from patients who have had a significant health event related to their cirrhosis, such as worsening symptoms or complications that required hospitalization.
To be eligible for this study, participants must be adults with liver cirrhosis and must have been admitted to the hospital for a decompensating event, which means their condition has gotten worse. They also need to provide their consent to participate in the study. The trial is currently looking for participants and welcomes individuals of all genders. Those who join will be part of a registry that helps researchers gather valuable information about how cirrhosis affects patients and how best to manage it.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • liver cirrhosis (primarily on clinical grounds)
- • decompensating event leading to hospital admission
- • informed consent
- Exclusion Criteria:
- • declined consent
About F.D. Roosevelt Teaching Hospital With Policlinic Banska Bystrica
F.D. Roosevelt Teaching Hospital, in collaboration with Policlinic Banská Bystrica, is a prominent clinical trial sponsor dedicated to advancing medical research and improving patient care. Located in Banská Bystrica, Slovakia, this esteemed institution combines academic expertise with clinical practice, facilitating innovative studies across various medical disciplines. With a commitment to ethical standards and patient safety, F.D. Roosevelt Teaching Hospital aims to contribute valuable insights to the scientific community while fostering a collaborative environment for researchers and healthcare professionals. Through their rigorous research initiatives, they strive to enhance treatment options and outcomes for diverse patient populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Banska Bystrica, , Slovakia
Patients applied
Trial Officials
Lubomir Skladany, MD PhD
Principal Investigator
F.D.Roosevelt Teaching Hospital, Banska Bystrica, Slovakia
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials